Business Description
Creo Medical Group PLC
ISIN : GB00BZ1BLL44
Description
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.23 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.33 | |||||
| Beneish M-Score | -2.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.1 | |||||
| 3-Year EBITDA Growth Rate | 21 | |||||
| 3-Year EPS without NRI Growth Rate | 17.8 | |||||
| 3-Year FCF Growth Rate | 10.7 | |||||
| 3-Year Book Growth Rate | -24.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 31.48 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.23 | |||||
| 9-Day RSI | 42.78 | |||||
| 14-Day RSI | 41.33 | |||||
| 6-1 Month Momentum % | -20.65 | |||||
| 12-1 Month Momentum % | 4.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.83 | |||||
| Quick Ratio | 3.01 | |||||
| Cash Ratio | 1.87 | |||||
| Days Inventory | 199.38 | |||||
| Days Sales Outstanding | 77.42 | |||||
| Days Payable | 113.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.2 | |||||
| Shareholder Yield % | -24.51 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.68 | |||||
| Operating Margin % | -80.52 | |||||
| Net Margin % | -70.46 | |||||
| FCF Margin % | -75.32 | |||||
| ROE % | -36.55 | |||||
| ROA % | -27.07 | |||||
| ROIC % | -39.91 | |||||
| ROC (Joel Greenblatt) % | -115.68 | |||||
| ROCE % | -35.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.31 | |||||
| PB Ratio | 2.02 | |||||
| Price-to-Tangible-Book | 3.69 | |||||
| EV-to-EBIT | -4.56 | |||||
| EV-to-Forward-EBIT | -7.97 | |||||
| EV-to-EBITDA | -5.32 | |||||
| EV-to-Forward-EBITDA | -9.55 | |||||
| EV-to-Revenue | 3.57 | |||||
| EV-to-Forward-Revenue | 2.71 | |||||
| EV-to-FCF | -4.59 | |||||
| Price-to-Net-Current-Asset-Value | 5.54 | |||||
| Earnings Yield (Greenblatt) % | -21.94 | |||||
| FCF Yield % | -19.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Creo Medical Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 30.8 | ||
| EPS (TTM) (£) | -0.07 | ||
| Beta | 0.96 | ||
| Volatility % | 70.64 | ||
| 14-Day RSI | 41.33 | ||
| 14-Day ATR (£) | 0.011436 | ||
| 20-Day SMA (£) | 0.341575 | ||
| 12-1 Month Momentum % | 4.29 | ||
| 52-Week Range (£) | 0.2912 - 0.5 | ||
| Shares Outstanding (Mil) | 361.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Creo Medical Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Creo Medical Group PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Creo Medical Group PLC Frequently Asked Questions
What is Creo Medical Group PLC(LSE:CREO)'s stock price today?
The current price of LSE:CREO is £0.33. The 52 week high of LSE:CREO is £0.50 and 52 week low is £0.29.
When is next earnings date of Creo Medical Group PLC(LSE:CREO)?
The next earnings date of Creo Medical Group PLC(LSE:CREO) is 2024-09-12 Est..
Does Creo Medical Group PLC(LSE:CREO) pay dividends? If so, how much?
Creo Medical Group PLC(LSE:CREO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers